facebook-page-view
Advertisement

Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

By Sneha Shah

  • 11 Sep 2012
Premium
Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B
Pfizer

Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with knowledge of the development told VCCircle. This would be the third largest M&A deal in the pharmaceutical sector in India, behind ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement